HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 06-13-2009, 03:53 PM   #1
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
Regarding surgery,

1: Med Hypotheses. 2009 Jun 9. [Epub ahead of print]
Primary tumor resection may improve prognosis for nonoperable advanced breast cancer.

Zhang N, Yang Q.
Department of Breast Surgery, Qilu Hospital, Shandong University School of Medicine, Wenhua West Road No. 107, Ji'nan, Shandong 250012, PR China.
Breast cancer has become a powerful killer worldwide that leads to the most global death among women, especially, the nonoperable stage IV breast cancer attracts lots of attentions for its difficulties of treatment. Recently, accumulating evidences hold a promise that resection of the primary tumor can improve the survival of patients with stage IV breast cancer. In order to explain its possible mechanisms, we took a deep insight into the existing rationales and focus on the crosstalks between them. We proposed that breast stem cell niche plays a significant role in the metastatic facilitation. On one hand, cancer stem cells in the niche can express productions making it more adhesive to the metastatic site. On the other hand, the niche has a positive effect on the cellular quiescence accelerating metastasis. Based on the cancer stem cells niche theory, we hypothesized that resection of the primary tumor may be a new avenue to improve the survival and the quality of life for advanced breast cancer patients.
PMID: 19520521 [PubMed - as supplied by publisher
Rich66 is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 09:06 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter